Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula(TM) RSV Molecular Point of Care Test
Accula RSV Test FDA Cleared for Both Children and Adults
SAN DIEGO, Nov. 27, 2018 -- (Healthcare Sales & Marketing Network) -- Mesa Biotech Inc., is a privately held, molecular diagnostic company that has developed an affordable and easy to operate PCR... Diagnostics, FDA Mesa Biotech, Accula RSV, respiratory syncytial virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news